Cart
sales@molnova.com
Goodyeroside A
CAS No. 211107-44-7
Goodyeroside A( ——— )
Catalog No. M38399 CAS No. 211107-44-7
Goodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity. It can inhibit liver damage induced by carbon tetrachloride in primary cultured rat hepatocytes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGoodyeroside A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGoodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity. It can inhibit liver damage induced by carbon tetrachloride in primary cultured rat hepatocytes.
-
DescriptionGoodyeroside A is a glycoside compound derived from the plant Goodyera that exhibits significant hepatoprotective activity.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number211107-44-7
-
Formula Weight264.23
-
Molecular FormulaC10H16O8
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Du XM, et al. Hepatoprotective aliphatic glycosides from three Goodyera species. Biol Pharm Bull. 2000 Jun;23(6):731-4. ?
molnova catalog
related products
-
AC 7739
AC 7739 is a microtubule protein binding agent with anticancer and antitumor activity that inhibits advanced solid tumors and in situ transplanted tumors.
-
L-Aspartic Acid 4-Be...
L-Aspartic Acid 4-Benzyl Ester is a chemical compound.
-
Tezepelumab
Tezepelumab (AMG 157) is a humanized monoclonal antibody (IgG2λ) targeting TSLP that prevents TSLP from interacting with its heterodimer receptor. Tezepelumab can be used to study advanced asthma disease.
